Inve India ▾

Vijaya Diagnostic Centre share price & results

Vijaya Diagnostic Centre Limited· Healthcare

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Largest B2C integrated pathology-radiology diagnostic chain in India; 162 centres, hub-and-spoke model

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue231 ₹ crore+22.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin43.0 %+4.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit53.0 ₹ crore+35.9% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity21.30 %−0.2 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin11.18 %−8.1 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)20.20 %−4.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

5 of 5 judged targets kept · 10 open · verdicts reflect calls analysed to Q1 FY27.

Vijaya Diagnostic Centre Limited management guidance track record on Inve: 15 targets tracked across analysed earnings calls (5 achieved, 0 missed, 10 open).

TargetOriginal wordingSaidLatest callVerdict
Revenue Growth CAGR15% plus CAGR over the next 2-3 years
Call transcript, Q4 FY25 · 12 May 2025		Q4 FY25Q1 FY27:The first year (FY26) of the 2-3 year promise was achieved with 19.5% growth. The promise is considered fulfilled for its initial leg.
Call transcript, Q1 FY27 · 7 Aug 2026		Achieved
FY27 CapexRs.100 to Rs.120 crores
Call transcript, Q2 FY26 · 4 Nov 2025		Q2 FY26Q1 FY27:Guidance revised up again to INR 190-195 crores for FY27 to accommodate accelerated expansion, including 9 hubs and a flagship Bangalore facility.
Call transcript, Q1 FY27 · 7 Aug 2026		Revised Up
New Hub Breakeven Timeline1 year from opening
Call transcript, Q4 FY25 · 12 May 2025		Q4 FY25Q1 FY27:2 new hubs commissioned in Q1 (Bengaluru, Gachibowli). While too early to assess breakeven, the company has a consistent track record of achieving this well within the 1-year target.
Call transcript, Q1 FY27 · 7 Aug 2026		On Track

Source: Inve Guidance Tracker for Vijaya Diagnostic Centre Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

10 of Vijaya Diagnostic Centre Limited's 15 targets are still open. See which are on track and which have gone quiet. The 3 above are the free sample; 12 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,395.8 +0.46% · +₹6.4

Last close 26 Oct 2026 · NSE · INR · Source: Inve

Performance +41.1% 1Y

₹1.0k₹1.2k₹1.4k₹1.6kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 4 Nov 2025Q3 FY26 — 13 Feb 2026Q4 FY26 — 8 May 2026Q1 FY27 — 7 Aug 2026

1Y: ₹989.4 on 24 Oct 2025 → ₹1,395.8. High ₹1,570.7 (23 Sept 2026), low ₹861.4 (30 Mar 2026).

Previous close
₹1,389.4
Market cap
₹14.4k Cr
52-week range
₹861.4 – ₹1,570.7
One year
+39.64%
Price to earnings (TTM to Jun 2026)
76.88×
Return on equity (TTM to Jun 2026)
21.30%

Overview

Symbol
NSE:VIJAYA
Exchange
NSE
Currency
INR

What Vijaya Diagnostic Centre Limited does

Based on the company's own presentations, annual report and earnings calls.

Vijaya Diagnostic Centre operates an integrated network of diagnostic centres offering both pathology (lab testing) and radiology (imaging) services under one roof, primarily serving walk-in retail (B2C) patients. The company runs on a hub-and-spoke model, with larger flagship hubs supported by smaller satellite spoke centres, and also offers online booking and home sample collection. It has grown from a single Hyderabad centre founded in 1981 into a multi-city chain, expanding organically and via acquisitions (PH Diagnostic Centre in Pune, co-branded Vijaya PH; merger of Medinova Diagnostic Services in Kolkata) into West and East India.

Segments

  • Pathology
  • Radiology
Diagnostic centres
162
Cities and towns covered
27
NABL-accredited labs
17
Radiologists, lab doctors & physicians
350+
MRI machines
43
CT machines
40
Founded 1981Headquarters Hyderabad, Telangana Company website

How the price took the results

close before → close after

Q1 FY27
−1.4%
7 Aug
Q4 FY26
+5.9%
8 May
Q3 FY26
−0.7%
13 Feb
Q2 FY26
+0.5%
4 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Vijaya Diagnostic Centre Limited

Free account: one company. Everything above stays public.

Write why you follow Vijaya Diagnostic Centre Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Vijaya Diagnostic Centre Limited

Guides on how to read this kind of business and the numbers that matter.